Research reveals widespread use of ineffective COVID-19 treatments after FDA deauthorized their use
Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal antibodies (bamlanivimab/etesevimab ...
Aug 29, 2022
0
56